Incidence of brain metastases after first line chemotherapy in breast cancer patients treated with or without trastuzumab

被引:0
|
作者
Ferretti, G.
Felici, A.
Pino, M. S.
Carlini, P.
Fabi, A.
Sperduti, I
Cognetti, F.
Papaldo, P.
机构
[1] Ist Nazl Tumori Regina Elena, Div Oncol Med A, Rome, Italy
[2] Ist Nazl Tumori Regina Elena, Biostat Unit, Rome, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:XI13 / XI13
页数:1
相关论文
共 50 条
  • [1] Clinicopathological study of brain metastases in breast cancer patients treated with or without trastuzumab.
    Saito, Y
    Tokuda, Y
    Suzuki, Y
    Umemura, S
    Osamura, RY
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 51S - 51S
  • [2] High incidence of brain metastases in advanced breast cancer (AB) patients (PTS) treated with trastuzumab
    Malossi, A.
    Seles, E.
    Sozzi, P.
    Paris, M. K.
    Cantele, V
    Clerico, M.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI12 - XI12
  • [3] Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab
    Yau, T
    Swanton, C
    Chua, S
    Sue, A
    Walsh, G
    Rostom, A
    Johnston, SR
    O'Brien, MER
    Smith, IE
    [J]. ACTA ONCOLOGICA, 2006, 45 (02) : 196 - 201
  • [4] Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer
    Clayton, AJ
    Danson, S
    Jolly, S
    Ryder, WDJ
    Burt, PA
    Stewart, AL
    Wilkinson, PM
    Welch, RS
    Magee, B
    Wilson, G
    Howell, A
    Wardley, AM
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 (04) : 639 - 643
  • [5] Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer
    A J Clayton
    S Danson
    S Jolly
    W D J Ryder
    P A Burt
    A L Stewart
    P M Wilkinson
    R S Welch
    B Magee
    G Wilson
    A Howell
    A M Wardley
    [J]. British Journal of Cancer, 2004, 91 : 639 - 643
  • [6] Comment on: Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab
    Errante, Domenico
    Bernardi, Daniele
    Bianco, Antonio
    Salvagno, Luigi
    [J]. ACTA ONCOLOGICA, 2007, 46 (04) : 565 - 566
  • [7] High incidence of brain metastases in HER2-overexpressing metastatic breast cancer (MBC) patients (pts) treated with trastuzumab and chemotherapy
    Gori, S.
    Rimondini, S.
    De Angelis, V.
    Sidoni, A.
    Mosconi, A. M.
    Aristei, C.
    Franceschi, E.
    Esposti, R. Degli
    Colozza, M.
    Crino, L.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 115 - 116
  • [8] High incidence of cerebral metastases in patients with metastatic breast cancer treated with trastuzumab
    Clayton, A.
    Danson, S.
    Jolly, S.
    Ryder, D.
    Burt, R.
    Stewart, A.
    Wilkinson, P.
    Magee, B.
    Wilson, G.
    Wardley, A.
    [J]. EJC SUPPLEMENTS, 2004, 2 (03): : 127 - 127
  • [9] The incidence and treatment outcome after radiotherapy for brain metastases in HER-2-positive metastatic breast cancer patients treated with trastuzumab
    Arif, S.
    Barrett-Lee, P. J.
    Jordan, C.
    [J]. CLINICAL ONCOLOGY, 2006, 18 (09) : 719 - 720
  • [10] CNS metastases in breast cancer patients treated with trastuzumab
    Globokar, T
    Borstnar, S
    Cufer, T
    Pajk, B
    Cervek, J
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 278 - 279